Kyntra Bio, Inc.
KYNB· Nasdaq
KYNBKyntra Bio, Inc.
Source filing unavailable
| Metric | Q1 2015 | Q1 2014 |
|---|---|---|
| Revenue | $16.30M | $17.88M |
| Net Income | -$46.37M | -$16.24M |
| EPS Diluted | -$0.78 | -$1.23 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kyntra Bio, Inc. · CIK 921299 · Engraved from SEC EDGAR
